SMN1 and chronic obstructive pulmonary disease: Analysis of clinical samples demonstrated that COPD patients with increased serum and lung β2M levels had increased expression of TGF-β1, Smad4, and a-SMA, and increased alveolar wall/septal thickness, resulting in lower DLCO values and fibrosis changes.